Learning Objectives
Upon completion of this activity, participants should be able to:
Describe the results of recent studies of novel antiretroviral agents currently in development for the treatment of HIV.
Discuss data from clinical trials of agents used in first-line regimens and the role of monotherapy in the management of HIV-infected patients.
Review data on the emergence of resistance mutations during antiretroviral therapy.
CCO Expert Recap combining slides with audio commentary
by Joel E. Gallant, MD, MPH. Topics covered include:
-
First-line Regimens & Treatment Strategies
-
Insights on Immune Response
-
Resistance
-
Pharmacokinetic Studies
-
Novel Antiretroviral
Agents